Hypertension and cardiac arrhythmias: A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Gregory Y.H. Lip, Antonio Coca, Thomas Kahan, Giuseppe Boriani, Antonis S. Manolis, Michael Hecht Olsen, Ali Oto, Tatjana S. Potpara, Jan Steffel, Francisco Marín, Márcio Jansen De Oliveira Figueiredo, Giovanni De Simone, Wendy S. Tzou, Chern En Chiang, Bryan Williams, Gheorghe Andrei Dan, Bulent Gorenek, Laurent Fauchier, Irina Savelieva, Robert HatalaIsabelle Van Gelder, Jana Brguljan-Hitij, Serap Erdine, Dragan Lovic, Young Hoon Kim, Jorge Salinas-Arce, Michael Field

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.

Original languageEnglish
Pages (from-to)891-911
Number of pages21
JournalEuropace
Volume19
Issue number6
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Cardiology
Cardiac Arrhythmias
Consensus
Hypertension
Atrial Fibrillation
Heart Failure
Blood Pressure
Sodium Chloride Symporter Inhibitors
Hypokalemia
Peripheral Arterial Disease
Left Ventricular Hypertrophy
Advisory Committees
Chronic Renal Insufficiency
Health Personnel
Antihypertensive Agents
Electrolytes
Coronary Artery Disease
Heart Diseases
Joints
Stroke

Keywords

  • Arrhythmias
  • Atrial fibrillation
  • EHRA consensus document
  • Hypertension
  • Left ventricular hypertrophy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Hypertension and cardiac arrhythmias : A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). / Lip, Gregory Y.H.; Coca, Antonio; Kahan, Thomas; Boriani, Giuseppe; Manolis, Antonis S.; Olsen, Michael Hecht; Oto, Ali; Potpara, Tatjana S.; Steffel, Jan; Marín, Francisco; De Oliveira Figueiredo, Márcio Jansen; De Simone, Giovanni; Tzou, Wendy S.; Chiang, Chern En; Williams, Bryan; Dan, Gheorghe Andrei; Gorenek, Bulent; Fauchier, Laurent; Savelieva, Irina; Hatala, Robert; Van Gelder, Isabelle; Brguljan-Hitij, Jana; Erdine, Serap; Lovic, Dragan; Kim, Young Hoon; Salinas-Arce, Jorge; Field, Michael.

In: Europace, Vol. 19, No. 6, 01.06.2017, p. 891-911.

Research output: Contribution to journalArticle

Lip, GYH, Coca, A, Kahan, T, Boriani, G, Manolis, AS, Olsen, MH, Oto, A, Potpara, TS, Steffel, J, Marín, F, De Oliveira Figueiredo, MJ, De Simone, G, Tzou, WS, Chiang, CE, Williams, B, Dan, GA, Gorenek, B, Fauchier, L, Savelieva, I, Hatala, R, Van Gelder, I, Brguljan-Hitij, J, Erdine, S, Lovic, D, Kim, YH, Salinas-Arce, J & Field, M 2017, 'Hypertension and cardiac arrhythmias: A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)', Europace, vol. 19, no. 6, pp. 891-911. https://doi.org/10.1093/europace/eux091
Lip, Gregory Y.H. ; Coca, Antonio ; Kahan, Thomas ; Boriani, Giuseppe ; Manolis, Antonis S. ; Olsen, Michael Hecht ; Oto, Ali ; Potpara, Tatjana S. ; Steffel, Jan ; Marín, Francisco ; De Oliveira Figueiredo, Márcio Jansen ; De Simone, Giovanni ; Tzou, Wendy S. ; Chiang, Chern En ; Williams, Bryan ; Dan, Gheorghe Andrei ; Gorenek, Bulent ; Fauchier, Laurent ; Savelieva, Irina ; Hatala, Robert ; Van Gelder, Isabelle ; Brguljan-Hitij, Jana ; Erdine, Serap ; Lovic, Dragan ; Kim, Young Hoon ; Salinas-Arce, Jorge ; Field, Michael. / Hypertension and cardiac arrhythmias : A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). In: Europace. 2017 ; Vol. 19, No. 6. pp. 891-911.
@article{d63cf80c7218462e90c102b8173d770a,
title = "Hypertension and cardiac arrhythmias: A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulaci{\'o}n Card{\'i}aca y Electrofisiolog{\'i}a (SOLEACE)",
abstract = "Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci{\'o}n Card{\'i}aca y Electrofisiolog{\'i}a (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.",
keywords = "Arrhythmias, Atrial fibrillation, EHRA consensus document, Hypertension, Left ventricular hypertrophy",
author = "Lip, {Gregory Y.H.} and Antonio Coca and Thomas Kahan and Giuseppe Boriani and Manolis, {Antonis S.} and Olsen, {Michael Hecht} and Ali Oto and Potpara, {Tatjana S.} and Jan Steffel and Francisco Mar{\'i}n and {De Oliveira Figueiredo}, {M{\'a}rcio Jansen} and {De Simone}, Giovanni and Tzou, {Wendy S.} and Chiang, {Chern En} and Bryan Williams and Dan, {Gheorghe Andrei} and Bulent Gorenek and Laurent Fauchier and Irina Savelieva and Robert Hatala and {Van Gelder}, Isabelle and Jana Brguljan-Hitij and Serap Erdine and Dragan Lovic and Kim, {Young Hoon} and Jorge Salinas-Arce and Michael Field",
year = "2017",
month = "6",
day = "1",
doi = "10.1093/europace/eux091",
language = "English",
volume = "19",
pages = "891--911",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Hypertension and cardiac arrhythmias

T2 - A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

AU - Lip, Gregory Y.H.

AU - Coca, Antonio

AU - Kahan, Thomas

AU - Boriani, Giuseppe

AU - Manolis, Antonis S.

AU - Olsen, Michael Hecht

AU - Oto, Ali

AU - Potpara, Tatjana S.

AU - Steffel, Jan

AU - Marín, Francisco

AU - De Oliveira Figueiredo, Márcio Jansen

AU - De Simone, Giovanni

AU - Tzou, Wendy S.

AU - Chiang, Chern En

AU - Williams, Bryan

AU - Dan, Gheorghe Andrei

AU - Gorenek, Bulent

AU - Fauchier, Laurent

AU - Savelieva, Irina

AU - Hatala, Robert

AU - Van Gelder, Isabelle

AU - Brguljan-Hitij, Jana

AU - Erdine, Serap

AU - Lovic, Dragan

AU - Kim, Young Hoon

AU - Salinas-Arce, Jorge

AU - Field, Michael

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.

AB - Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.

KW - Arrhythmias

KW - Atrial fibrillation

KW - EHRA consensus document

KW - Hypertension

KW - Left ventricular hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=85021828954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021828954&partnerID=8YFLogxK

U2 - 10.1093/europace/eux091

DO - 10.1093/europace/eux091

M3 - Article

C2 - 28881872

AN - SCOPUS:85021828954

VL - 19

SP - 891

EP - 911

JO - Europace

JF - Europace

SN - 1099-5129

IS - 6

ER -